Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

ImmunityBio has the lowest figure of the 24 biotech ranked by net assets, at -SAR 1.9B, followed by Halozyme Therapeutics (SAR 183.1M) and Kodiak Sciences (SAR 590.3M). Figures as of 18 Nov 2026, 15:56 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
ImmunityBio-SAR 1.9B
Median
SAR 7.6B
Combined market value
SAR 3.15T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ImmunityBioIBRX · Health Care-SAR 1.9BSAR 26.4BSAR 24.83 5.75% up 193% up United States
2Halozyme TherapeuticsHALO · Health CareSAR 183.1MSAR 41.6BSAR 365.05 1.41% up 37% up United States
3Kodiak SciencesKOD · Health CareSAR 590.3MSAR 23.9BSAR 364.78 0.46% up 396% up United States
4Adaptive BiotechnologiesADPT · Health CareSAR 820.7MSAR 17.4BSAR 107.77 0.84% up 88% up United States
5Scholar Rock HoldingSRRK · Health CareSAR 920.8MSAR 21.6BSAR 176.82 4.57% up 14% up United States
6Twist BioscienceTWST · Health CareSAR 1.8BSAR 29.6BSAR 433.73 3.24% up 340% up United States
7CG OncologyCGON · Health CareSAR 2.8BSAR 26.8BSAR 300.28 1.41% up 85% up United States
8ImmunovantIMVT · Health CareSAR 3.2BSAR 26.1BSAR 126.20 1.31% up 43% up United States
9Krystal BiotechKRYS · Health CareSAR 4.6BSAR 34.3BSAR 1,157.95 3.40% up 46% up United States
10Kymera TherapeuticsKYMR · Health CareSAR 5.9BSAR 38.5BSAR 450.95 1.07% down 87% up United States
11Revolution MedicinesRVMD · Health CareSAR 6.1BSAR 130.2BSAR 601.89 1.37% down 131% up United States
12CRISPR TherapeuticsCRSP · Health CareSAR 7.2BSAR 15.2BSAR 156.30 3.79% up 21% down Switzerland
13RepligenRGEN · Health CareSAR 7.9BSAR 41.3BSAR 645.32 6.08% up 5% up United States
14Bio-TechneTECH · Health CareSAR 7.9BSAR 42.9BSAR 272.85 0.15% up 26% up United States
15ExelixisEXEL · Health CareSAR 8.1BSAR 63BSAR 258.29 0.53% up 63% up United States
16VaxcytePCVX · Health CareSAR 10.1BSAR 34.6BSAR 218.57 1.90% down 22% up United States
17Neurocrine BiosciencesNBIX · Health CareSAR 12.2BSAR 61.9BSAR 611.14 1.80% down 20% up United States
18QiagenQGEN · Health CareSAR 14.2BSAR 38.4BSAR 186.14 0.25% down 12% up Netherlands
19argenxARGX · Health CareSAR 27.5BSAR 223.7BSAR 3,557.04 0.08% up 4% up Belgium
20ModernaMRNA · Health CareSAR 32.4BSAR 307.3BSAR 759.58 2.08% down 755% up United States
21AmgenAMGN · Health CareSAR 32.5BSAR 907.5BSAR 1,677.71 2.33% down 34% up United States
22BiogenBIIB · Health CareSAR 68.5BSAR 138.5BSAR 937.26 0.37% down 49% up United States
23BioNTechBNTX · Health CareSAR 80BSAR 78.2BSAR 315.42 0.91% down 16% down Germany
24Gilead SciencesGILD · Health CareSAR 85.2BSAR 784.2BSAR 632.27 1.00% down 33% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).

Questions and answers

Which biotech have the lowest net assets?

ImmunityBio (-SAR 1.9B), Halozyme Therapeutics (SAR 183.1M) and Kodiak Sciences (SAR 590.3M) have the lowest net assets of the 24 biotech ranked here as of 18 Nov 2026, 15:56 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of SAR 3.15T as of 18 Nov 2026, 15:56 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.